| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Chief Legal Officer
2 companies
Zdraveski Zoran is a See Remarks at TCRX, with reported holdings spanning 2 companies. Recent filings cover 1 purchase and 3 sales. Those positions are worth an estimated $2.0M at current prices.
Zdraveski Zoran's largest disclosed position is in DNTH as See Remarks, worth about $2.0M. The recent filings there lean toward selling, a net 12,083 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 23, 2024 | TCRX Tscan Therapeutics, Inc. | See Remarks | Sale+OE | 164,686 | $5.78 | $952,115.64 | -97.2% | -30.5% | -67.0% | |
| Sep 23, 2021 | TCRX Tscan Therapeutics, Inc. | Chief Legal Officer | Buy | 4,716 | $7.48 | $35,255.40 | New | -35.9% | -62.5% | |
| Dec 24, 2019 | DNTH Dianthus Therapeutics, Inc. /de/ | See Remarks | Sell | 7,902 | $16.00 | $126,432.00 | -5.8% | - | - | |
| Dec 23, 2019 | DNTH Dianthus Therapeutics, Inc. /de/ | See Remarks | Sell | 4,181 | $16.03 | $67,021.43 | -3.0% | - | - |